University of Virginia
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Virginia sits in the top decile of US sponsors by registered trial count (#78 of 15,742 sponsors by registered trial count).
University of Virginia: 449 sponsored US clinical trials, 101 recruiting.
University of Virginia sponsors 449 registered US clinical trials on ClinicalTrials.gov, 101 of them currently recruiting, and 281 completed. 40 of these trials are in Phase 3-4 (later-stage) and 109 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 1 Diabetes Mellitus, with 9 trials.
Top-decile sponsor footprint
University of Virginia ranks in the top decile of sponsors by registered trial count (#78 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
281 of 317 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
449 total, page 7 of 9
Determine the Safety/Efficacy of Ticagrelor for Maintaining Patency of Arterio-Venous Fistulae Created for Hemodialysis
NCT02335099
The Effect of Type 1 Diabetes on Pan-Arterial Vascular Function and Insulin Sensitivity in Humans
NCT02490124
Pharmacokinetics of Bolus Versus Continuous Cefazolin Infusion in Patients Undergoing Major Surgery
NCT02058979
The Impact of Riboflavin on the Severity and Duration of Sports Related Concussion
NCT02235337
VentFirst Pilot: Ventilating Preterm Infants During Delayed Cord Clamping
NCT02391389
A Study of Patient-reported Outcomes in Patients With Lung or Esophageal Cancer
NCT02239328
Comprehensive Magnetic Resonance in Peripheral Arterial Disease.3
NCT02388685
Effect of Metformin on Insulin Sensitivity and Pan-Arterial Vascular Function in Adults With Metabolic Syndrome
NCT02633488
USS Virginia Closed-Loop for Overnight Control in Type 1 Diabetes
NCT02131766
The Use of Near Infrared Spectroscopy (NIRS) to Estimate Intracranial Pressure (ICP)
NCT01850069
Microvascular Disease Exercise Trial
NCT02045459
Full Day and Night Closed-Loop With DiAs Platform
NCT02147860
Dexamethasone Versus Burr Hole Craniostomy for Symptomatic Chronic Subdural Hematoma
NCT02111785
Study of Airflow in the Lungs Using Helium MRI
NCT02154568
Phase 0 Biodistribution of Novel Imaging for Resectable Pancreatic Cancer
NCT01962909
RNA Cloning and Visualization in Human Atherosclerosis
NCT01928095
Evaluating the Asthmatic Response to an Experimental Infection With Rhinovirus in the Atopic
NCT02111772
A Mindfulness Based Application for Smoking Cessation
NCT01982110
Optimizing Closed-Loop Control of Type 1 Diabetes Mellitus in Adolescents
NCT01890954
Diabetes Assistant (DiAs) Control-to-Range (CTR) Nocturnal Closed-Loop Camp Study
NCT01973413
Phase 2 Study of Adaptive Insulin Meal Supervisor (AIMS) in Adults With Type 1 Diabetes Mellitus
NCT01839370
Insertion Technique in Large Volume Paracentesis
NCT02310165
Zibotentan, an Endothelin Receptor Antagonist, Patients With Intermittent Claudication
NCT01890135
Response of Pulse Pressure Variation in PA Catheter Tracing to IV Fluid Bolus in the ICU
NCT02419404
Lifestyle Modification for Type 2 Diabetes Involving Reduction of After-meal Blood Glucose Elevations
NCT02432391
Biobehavioral Mechanisms of Glucose Variability
NCT01835964
Evaluation of a Simulation-Based Educational Tool for Personalized Feedback in Insulin Therapy Management
NCT01767831
Treatment With Omalizumab to Improve the Asthmatic Response to Rhinovirus Experimental Infection With Rhinovirus
NCT02388997
Validation of Peripheral Pressure Volume Loops and Ultrasound-derived "Cardiac Power" by Comparison With Invasive Left Ventricular Pressure Volume Loops
NCT01750450
Validation of Pulse Wave Doppler Demodulation Algorithm for the Continuous, Non-invasive Measurement of Blood Flow Velocity
NCT01750125
Topical Umbilical Cord Care for the Prevention of Colonization and Invasive Infections
NCT01886001
Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System Efficacy
NCT01714505
Evaluating and Improving Functional Driving Vision of Patients With Astigmatism
NCT02624791
Use of Near Infrared Spectroscopy to Measure Intracranial ScvO2
NCT01746576
Lung Cancer Information Study (LCIS-R01)
NCT01924416
Development of an Advisory System for Glycemic Control During the Menstrual Cycle in Patient With Type 1 Diabetes
NCT01653210
Effect of Probiotic on the Innate and Adaptive Host Response to Rhinovirus (EPIARR)
NCT01669603
Study of Dexmedetomidine in Spine Surgery
NCT01850017
Mindfulness-Based Relapse Prevention for Alcohol Use Disorders in Remission
NCT02147483
Development and Feasibility of an Internet Intervention for Adults With Spinal Cord Injury to Prevent Pressure Ulcers
NCT01885962
Feasibility Study of Closed Loop Control in Type 1 Diabetes Using Heart Rate Monitoring as an Exercise Marker
NCT01582139
Acute Effects of Progesterone on LH Pulses During the Follicular Phase (CRM006)
NCT01602679
Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial
NCT01369069
Outpatient Control-to-Range: System and Monitoring Testing
NCT01578980
Autologous Stem Cell Transplantation and Maintenance Therapy for Multiple Myeloma
NCT01617213
Study of Dovitinib (TKI258) in Adenoid Cystic Carcinoma
NCT01524692
Oral Immunotherapy for Peanut and Mammalian Meat Allergies
NCT02350660
Identifying Driving Risk Factors in Type 1 Diabetes and Their Reduction Via Internet Program (DiabetesDriving.Com)
NCT01563887
Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer
NCT01482728
Conditioning Treatment With Umbilical Cord Blood Transplant for Hematologic Malignancies
NCT01622556
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 58 |
| Phase 2 | 51 |
| Phase 3 | 14 |
| Phase 4 | 26 |
Therapeutic Areas
What is open in the University of Virginia pipeline
101 recruiting of 449 indexed (22% open); 281 completed (63%).
Phase mix: 40 late (III/IV) vs 109 early (I/II) (early-phase heavy).
Top condition: Type 1 Diabetes Mellitus (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Virginia: open-pipeline peers nationwide
Peers matched on 449 registered trials and 22% open enrollment, not the therapeutic-area sidebar.
University of Virginia sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 449 trials (± recruiting share)
- Medical College of Wisconsin · 447 trials · 21% recruiting
- Alliance for Clinical Trials in Oncology · 446 trials · 7% recruiting
- Boston Children's Hospital · 462 trials · 24% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
Sponsors near 22% open enrollment (± trial volume)
- Ohio State University Comprehensive Cancer Center · 23% recruiting · 341 trials
- University of Delaware · 23% recruiting · 106 trials
- University of Oklahoma · 22% recruiting · 358 trials
- ALX Oncology · 22% recruiting · 9 trials
Related
What to do with this University of Virginia page
449 registered trials is a research-attention snapshot, not an endorsement of University of Virginia or any single study.
- 101 of University of Virginia's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 1 Diabetes Mellitus is the condition University of Virginia studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 1 Diabetes Mellitus trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Virginia pipeline card: 449 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.